Skip to main content
E

Erthos

Erthos develops biodegradable packaging materials using a proprietary machine learning AI platform to accelerate the design of scalable biomaterials that replace traditional polystyrene and polypropylene. This technology addresses the environmental impact of plastic waste by providing sustainable alternatives for various applications in global supply chains.

Toronto, CanadaFounded 2018267K+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Conventional plastics like polystyrene and polypropylene contribute significantly to environmental pollution due to their slow degradation and reliance on fossil fuels. The development of sustainable alternatives is often slow and costly, hindering widespread adoption across global supply chains.

Solution

Erthos is developing biodegradable packaging materials using a proprietary machine learning (ML) AI platform to accelerate the design and production of scalable biomaterials. The company's technology aims to replace traditional plastics with sustainable alternatives derived from plant-based sources. By leveraging AI, Erthos streamlines the complex research and development processes involved in creating biomaterials, reducing the time and cost associated with bringing these materials to market. The resulting bioresins and bioadditives offer a drop-in replacement for conventional plastics in various applications, enabling brands to reduce their environmental footprint without compromising performance.

Target Audience

Erthos targets brands and manufacturers across various industries seeking sustainable alternatives to traditional plastics for packaging and product components.

Features

  • Proprietary ML-AI platform for rapid design and optimization of biomaterials
  • Bioresins designed as 1-for-1 alternatives to injection-grade polypropylene for caps and closures
  • Bioresins with high barrier properties suitable for personal care applications
  • Bioadditives to improve the functionality of PLA and act as alternatives to ESO
  • Focus on creating industry-scalable biomaterials for global supply chains
This profile is AI-generated and may contain inaccuracies.